HAT-PCR is non-inferior to NGS when quantifying measurable residual disease for myeloma

Author(s): Hughes, E; Blombery, P; Kannan, S; Khong, T; Spencer, A; Morley, A;
Details: Publication Year 2026-06,Volume 208,Issue #6,Page 2256-2259
Journal Title: British Journal of Haematology
Publication Type: Research article
Publisher: Wiley
Keywords: Mrd; Ngs; Pcr; hypermutation; myeloma
Department(s): Haematology
Publisher's Version: https://doi.org/10.1111/bjh.70478
Open Access at Publisher's Site: https://doi.org/10.1111/bjh.70478
Terms of Use/Rights Notice: Refer to copyright notice on published article.

Creation Date: 2026-04-28 02:39:58

Last Modified: 2026-06-30 12:00:01